alleviates the immune suppressive effect of sMIC and revamps endogenous anti-tumor immune responses. Therapy with B10G5 results in effective debulking of primary tumor and elimination of metastasis, with ... also…
Purpose: We aimed to explore the potential favourable roles of chemotherapy in promoting immune checkpoint blockade therapy in non-small cell lung cancer (NSCLC). Method: We combined chemotherapy gemcitabine with…
Immune Checkpoint Inhibitor (ICI) therapy is the most exciting development in cancer treatments in recent years. As of the end of 2021, more than a hundred of clinical trials have
related skin rash is common in patients receiving PD-1/PD-L1-based immune checkpoint inhibitor therapy. This study aimed to explore whether development of rash is predicative of outcomes ... patients with non-small cell…
effects and cost. Treatment for patients without immune checkpoint receptors or ligands remains an issue of concern. The cost of this therapy is huge ... further increased when treatment is required for adverse effects…
immune checkpoint inhibitor monotherapy, to improve the prognosis of ovarian cancer, multi-drug therapy including immune checkpoint inhibitors is necessary. In this short commentary, we highlight the need for studies
checkpoint therapy, which unleashes the immune system in order to augment the anti-cancer immune response, also increases the incidence of autoimmune diseases and induces an array of immune-related ... adverse effects…
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by unleashing the immune system to target and destroy tumor cells. Despite their significant success in cancers such as melanoma, non-small…
metastatic settings. We explore the details of adjunctive therapy for localized GAC and discuss the promising developments, including immune checkpoint inhibitors, for Microsatellite Instability High ... metastatic…
Cardiac toxicity from cancer therapies is a growing concern. Several treatments, including \textit{Immune Checkpoint Inhibitors} (ICIs), anthracyclines, and trastuzumab, can cause significant cardiac issues. Early…
discussion, we delve into the biological plausibility and clinical evidence supporting the impact of immune checkpoint inhibition on the development of atherosclerotic CV disease. Additionally, we offer insights on…
have emerged as one of the most common immune-related adverse events of Immune checkpoint blockade therapy with a reported incidence range of 2%-15% depending upon the Immune checkpoint ... study is to describe the…
relapsed cases. Recent insights into tumor immunology have led to the exploration of immune checkpoint inhibitors and biomarker-driven strategies to personalize treatment. This article examines the role of immune…
treatment modality is needed to achieve satisfactory oncologic outcomes. Triple therapy; sensitization for immune checkpoint therapy following combined inhibition of DNMT1 and EZH2 induces ovarian cancer cells to…
revolutionizing cancer therapy by enhancing antitumor immunity through innovative pharmacological interventions. This article reviews the role of immunopharmacology in cancer treatment, focusing on strategies to boost…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.